CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | KAITIN KENNETH I Director | Purchase | +10,000 | $0.55 | $5K | 11,407 |
| 2017-11-16 | Rubin Marc Director | Purchase | +25,000 | $0.98 | $25K | 51,596 |
| 2017-11-15 | Fattaey Ali Ph.D. President & CEO | Purchase | +50,000 | $1.06 | $53K | 115,890 |
| 2016-09-07 | Aurigene Discovery Technologies Ltd 10% owner | Purchase | +10,208,333 | $2.40 | $24.5M | 27,328,464 |
| 2014-08-27 | Fattaey Ali Ph.D. President & CEO | Purchase | +62,890 | $1.60 | $101K | 65,890 |
| 2013-12-11 | Fattaey Ali Ph.D. President & COO | Purchase | +3,000 | $2.52 | $8K | 3,000 |
| 2013-11-12 | GRAY MICHAEL CFO | Purchase | +10,000 | $2.86 | $29K | 107,304 |
| 2013-11-08 | Pienta Kenneth Director | Purchase | +20,000 | $2.95 | $59K | 30,000 |
| 2013-09-16 | Pienta Kenneth Director | Purchase | +10,000 | $4.37 | $44K | 10,000 |
| 2013-08-16 | MCNAB JAMES R Director | Purchase | +50,000 | $4.00 | $200K | 250,000 |
Page 1 of 1 · 10 trades